MATRIXX Software

Hyper-Converged Infrastructure

FiberSense | June 13, 2022

Rapidly expanding infrastructure sensing and monitoring company, Fiber Sense Limited (FiberSense), today announced the appointment of Chris Sharp, Digital Realty (NYSE: DLR) Chief Technology Officer (CTO), as a Non-Executive Director. Chris will join existing Chairman Bevan Slattery as Co-Chair. Sharp, having led technology teams across two of the largest data center operators in the world, brings an extensive background in championing the development of new technology strategies ...

Application Infrastructure

Keysight Technologies | December 02, 2021

Keysight Technologies, Inc. a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world, has joined the Anterix Active Ecosystem Program to help advance private Long-Term Evolution (LTE) broadband deployments in the United States. Launched in May 2021 the Anterix Active Ecosystem Program is a diverse group of over 65 innovators bringing technology, equipment and services to support utilities and ...

IT Systems Management,AWS

Pivotal Commware, Inc. | December 05, 2022

Pivotal Commware, global leader in 5G mmWave infrastructure products for the wireless edge, announces that Pivotal Turnkey is expanding 5G mmWave coverage for a Tier 1 mobile network operator (MNO) in Houston. Pivotal Turnkey provides an end-to-end solution using Pivotal’s mmWave product ecosystem. Turnkey delivers potential fixed wireless access (FWA) subscribers to MNOs at lower Total Cost of Ownership (TCO) – 25% to 35% the cost of fiber – and lower time-to-re...

Application Infrastructure

Simulations Plus | January 16, 2023

Simulations Plus, Inc. recently announced that its DILIsym Services (DSS) division released DILIsym® version X (DSX) Beta, the latest iteration of its flagship quantitative systems toxicology (QST) software for predicting and investigating drug-induced liver injury (DILI). DILIsym modeling aids vital drug development decisions by prevising the potential DILI risk of new drug candidates. The modeling also identifies the biochemical events that contribute to DILI caused by a med...